𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection

✍ Scribed by Onda, T; Yoshikawa, H; Yasugi, T; Yamada, M; Matsumoto, K; Taketani, Y


Book ID
109998446
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
179 KB
Volume
92
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Secondary cytoreductive surgery for pati
✍ Rong-Yu Zang; Zi-Ting Li; Jie Tang; Xi Cheng; Shu-Mo Cai; Zhi-Yi Zhang; Nelson N πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Abstract ## BACKGROUND This study was performed to address patient selection criteria and the role of secondary cytoreductive surgery (SCR) in patients with epithelial ovarian carcinoma (EOC) who had relapsed tumors after a progression‐free interval β©Ύ 3 months. ## METHODS One hundred seventee

The role of secondary cytoreductive surg
✍ Scott M. Eisenkop; Richard L. Friedman; Nick M. Spirtos πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

BACKGROUND. This study examined the impact of secondary cytoreductive surgery on survival of patients with recurrent epithelial ovarian carcinoma. ## METHODS. One hundred six patients with a disease free interval (DFI) ΟΎ 6 months after primary treatment underwent secondary cytoreductive surgery. M

Secondary cytoreductive surgery for recu
✍ Scott M. Eisenkop; Richard L. Friedman; He-Jing Wang πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 780 KB

Background. The prognosis for patients with recurrent epithelial ovarian cancer is poor. Most are treated with salvage chemotherapy. The role of secondary cytoreductive surgery is controversial. Hence, this prospective study was undertaken to determine the feasibility and benefit of secondary cytore